PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9421998

An augmented auditory feedback device.

M Batavia·J G Gianutsos·M Kambouris
View original source ↗Export metadata ↓

Abstract

An augmented auditory feedback device is described. The device can be easily and economically constructed and implemented during a patient's physical rehabilitation. The rationale is to provide an external source of information to the user in order to correct errors during weight-bearing activities. Possible applications of the augmented auditory feedback device include increasing symmetry and weight distribution during sitting, standing, and gait. Instructions regarding its construction are provided, and a case study using the device is presented. Improved midline alignment and weight distribution in sitting for a 2-hour duration was achieved by a stroke patient using the augmented auditory feedback device in conjunction with physical therapy.

Explore related subjects

Activities of Daily LivingAgedBiofeedback, PsychologyCerebrovascular DisordersHearingHumansMalePhysical Therapy ModalitiesPostural BalanceRehabilitationCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Batavia, J G Gianutsos, M Kambouris. 1997. An augmented auditory feedback device.. https://doi.org/10.1016/s0003-9993(97)90317-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.

BACKGROUND: Axillary lymph node dissection is commonly performed as part of the primary management of breast carcinoma. Its value in patient management, however, has recently been questioned. Few studies exist that document long term complications. METHODS: Four hundred thirty-two patients with Stage I or II breast carcinoma who were free of recurrence 2-5 years after surgery were identified. A cross-sectional survey was conducted to determine the prevalence of long term symptoms and complications as perceived by the patient, and patient and treatment factors that may have predicted complications were determined. Three hundred thirty of the 432 (76%) completed a mailed, self-administered questionnaire. In addition, the medical records of the 330 patients were reviewed. Patient and treatment factors were analyzed with logistic regression. RESULTS: Numbness was reported by 35% of patients at the time of the survey. Pain was noted in 30%, arm swelling in 15%, and limitation of arm movement in 8%. Eight percent reported episodes of infection or inflammation at some point since the diagnosis of breast carcinoma. The majority of symptoms were mild and interfered minimally with daily activities. Younger age (P=0.001) was associated with more frequent reporting of pain. Numbness was more common in younger patients (P=0.004) as well as in those with a history of smoking (P=0.012). There was a positive association of limitation of arm motion with adjuvant tamoxifen therapy (P=0.016). Arm swelling was associated with both younger age (P=0.004) and greater body surface area (P=0.008). Radiation therapy was associated with a higher frequency of infection or inflammation in the arm and/or breast (P=0.001). CONCLUSIONS: Mild symptoms, especially pain and numbness, are common 2-5 years after axillary lymph node dissection. The frequency of inflammation or infection in patients treated with radiation to the breast or chest wall after an axillary lymph node dissection may be greater than previously appreciated. Severe complications or symptoms that have a major impact on daily activities are uncommon. These findings should help health care providers and their patients with breast carcinoma weigh the pros and cons of axillary lymph node dissection.

Activities of Daily Living↗
PubMed1998

Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs.

We prospectively compared the impact on quality of life and cost effectiveness between ablation and medication as an initial strategy for patients with paroxysmal supraventricular tachycardia (SVT). Seventy-nine consecutive patients with newly documented paroxysmal SVT were treated with either ablation or medication. Health surveys (SF-36 and disease-specific questions) were obtained at baseline and after 12 months of follow up. Cost of health care utilization for the 6 months before and after treatment were measured. Both medication and ablation improved quality of life. However, ablation improved quality of life in more general health categories than medication. At follow up, ablation was associated with significantly improved quality of life in the bodily pain (63+/-24 vs 81+/-20, p <0.005), general health (69+/-21 vs 79+/-21, p <0.05), vitality (55+/-21 vs 66+/-22, p <0.05), and role emotion (78+/-36 vs 94+/-17, p <0.05) categories when compared with medication. Although both medication and ablation decreased frequency of disease-specific symptoms, ablation resulted in complete amelioration of symptoms in more patients (33% vs 74%). Potential long-term costs were similar for medication and ablation. In conclusion, ablation improves health-related quality of life to a greater extent, and in more aspects of general and disease-specific health than medication.

Activities of Daily Living↗
PubMed1998

Functional outcome of surgically and conservatively managed dens fractures.

STUDY DESIGN: Fifty-seven patients with dens fractures were identified from 1986 to 1996 at the authors' institution. Forty-six were available for reevaluation by two independent observers with a mean follow-up period of 26 months. OBJECTIVE: To determine by age and fracture type which treatment regimen provided the best functional outcome in patients with dens fractures. SUMMARY OF BACKGROUND DATA: There were no Type I fractures, but there were 37 Type II and 20 Type III fractures. Twenty-nine patients were under 60 years of age, and 28 were 60 years and older. Six patients had been treated by immediate C1-C2 posterior fusion, and five received treatment with a Philadelphia collar only. Forty-six patients were placed in a halo thoracic immobilizer with a symptomatic nonunion rate of 19.5%. These patients ultimately required posterior cervical fusion. METHODS: Final functional outcome, level of pain, and cervical range of motion were all statistically evaluated using multivariate analysis (Wilcoxon's two-sample test). The influence of age, fracture type, and treatment method were determined. RESULTS: There were no cases of short- or long-term neurologic deterioration in any of the patients in the study group. There was a significantly higher rate of complications associated with halo use in the older population. Pain scores were higher in Type II fractures and in patients treated conservatively with halo immobilization, especially those patients over 60 years of age. No statistically significant difference in these parameters were found. Older patients treated surgically did not have a better functional outcome score than those treated nonoperatively (P < 0.8). Persons over 60 years of age treated in a halo had a significantly (P < 0.05) decreased range of motion when compared with younger patients treated similarly. CONCLUSION: Patients over 60 years of age with a dens fracture had a higher complication rate and lower cervical range of motion when treated conservatively with a halo. Final functional outcome and overall pain levels, however, did not differ significantly by age group or treatment modality.

Activities of Daily Living↗